DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,653 Cr | ₹1,261 Cr | ₹2,459 Cr | ₹1,912 Cr | ₹1,947 Cr |
What is the latest Cash Flow from Operating Activities ratio of DIVIS LABORATORIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹1,653 Cr |
| Mar2024 | ₹1,261 Cr |
| Mar2023 | ₹2,459 Cr |
| Mar2022 | ₹1,912 Cr |
| Mar2021 | ₹1,947 Cr |
How is Cash Flow from Operating Activities of DIVIS LABORATORIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,653 Cr | 31.09 | |
| Mar2024 | ₹1,261 Cr | -48.72 | |
| Mar2023 | ₹2,459 Cr | 28.62 | |
| Mar2022 | ₹1,912 Cr | -1.80 | |
| Mar2021 | ₹1,947 Cr | - | |
Compare Cash Flow from Operating Activities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹165,511.4 Cr | -5.8% | -1.6% | 10.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -3.5% | -6.4% | -2.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,013.0 Cr | 1.4% | 7% | 23.7% | Stock Analytics | |
| CIPLA | ₹112,922.0 Cr | -4.7% | -6.8% | -0.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,115.0 Cr | -2.8% | -8.1% | -11.1% | Stock Analytics | |
| MANKIND PHARMA | ₹89,832.6 Cr | -1.1% | 3.3% | -13.4% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -5.8% |
-1.6% |
10.9% |
| SENSEX | -0.7% |
-1.9% |
8% |
You may also like the below Video Courses